N

Active Director Director DIN 08976854
DIN 08976854 First appointment Nov 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Neelakshi

Data last updated:

Neelakshi is a Director at Yuvaan Healthcare Private Limited (since 2020). The company operates in Healthcare. Yuvaan Healthcare Private Limited reported revenue of ₹11.67 Cr (FY 2025).

DIN 08976854
Primary Designation Director
Industry Healthcare
First Appointment 28 Nov 2020
Oldest Company Age 5 yrs
Largest company Yuvaan Healthcare Private Limited · ₹11.67 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yuvaan Healthcare Private Limited U85300WB2020PTC241600
Director28 Nov 20202020₹11.67 Cr (FY 2025)Active

Board colleagues of Neelakshi

NameDINCompanyDesignation
Rahul Prasad08976853Yuvaan Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yuvaan Healthcare Private Limited
Premium access

Shareholding and investment profile for Neelakshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelakshi

Neelakshi currently holds 1 directorship: Yuvaan Healthcare Private Limited (Director, since 28 Nov 2020, revenue ₹11.67 Cr (FY 2025)).

Neelakshi was first appointed on 28 Nov 2020 as Director at Yuvaan Healthcare Private Limited.

The current boards of Neelakshi's companies include Rahul Prasad (Yuvaan Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available